Gene Interactions and Blood Pressure Responses to Hypertension Medications
Author Information
Author(s): Sharon L. R. Kardia, Yan V. Sun, Sara C. Hamon, Ruth Ann Barkley, Eric Boerwinkle, Stephen T. Turner
Primary Institution: University of Michigan
Hypothesis
Does genetic variation in the adducin 2 gene influence blood pressure responses to antihypertensive drug therapies?
Conclusion
The study suggests that variations in the adducin 2 gene may affect blood pressure responses to specific antihypertensive medications.
Supporting Evidence
- Eight SNPs in the adducin 2 gene were significantly associated with systolic blood pressure in untreated hypertensives.
- The TT genotype at SNP rs1541582 was linked to higher systolic blood pressure in different drug treatment groups.
- Cross-validation methods were used to reduce false positive findings in the analysis.
Takeaway
Some people with high blood pressure might respond differently to medications based on their genes, which can help doctors choose the best treatment for them.
Methodology
The study used cross-validation statistical methods to analyze the effects of SNPs in the adducin 2 gene on blood pressure in hypertensive individuals treated with different antihypertensive drugs.
Potential Biases
Potential biases may arise from the prescribing preferences of physicians, which could affect the observed gene-drug interactions.
Limitations
The study design is community-based and lacks prospective data to document genetic influence on blood pressure response within individuals.
Participant Demographics
Participants were non-Hispanic white individuals with hypertension from Rochester, MN.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website